Literature DB >> 2685015

Sialic acid levels and lag time of growth in chemically defined medium containing 200 mM phosphate among strains of various serotypes of Streptococcus agalactiae.

Y Nagano1, N Nagano, S Takahashi, A Suzuki, Y Okuwaki.   

Abstract

The type-specific capsular polysaccharide antigen of Streptococcus agalactiae has in previous experimental studies been considered a significant antiphagocytic factor, whereas the lipoteichoic acid moiety has been suggested to be a factor in adherence to human fetal cell lines. Since epidemiological data concerning these cell constituents in strains from the genital tract are lacking, we attempted serotyping and analysis of these constituents of 100 vaginal isolates. The capsular polysaccharide level was shown to be the amount of sialic acid that occupied the terminal side chains of the polysaccharide. We carried out a study to ascertain whether strains exhibited a lag time of growth in a chemically defined medium containing 200 mM phosphate, which has been suggested to be characteristic of strains with high lipoteichoic acid levels. Strains were classified, on the basis of the results of distribution of sialic acid levels, into three categories: (i) strains with a low sialic acid content of equal to or less than 9 micrograms/mg of cell dry weight; (ii) strains with a moderate sialic acid content of more than 9 but less than 12 micrograms/mg of cell dry weight; and (iii) strains with a high sialic acid content of equal to or more than 12 micrograms/mg of cell dry weight. Strains that belonged to the last category, which, as previous experimental data indicate, are potentially virulent strains, were significantly distributed among isolates of types Ia (P less than 0.001) and III (P less than 0.05). On the other hand, strains exhibiting a lag time of growth in the above-mentioned medium were detected to a significant extent in type III isolates (P <0.02). These results may be related to the epidemiological finding that isolates from neonates with late-onset infection were more frequently serotype Ia and III isolates.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2685015      PMCID: PMC266982          DOI: 10.1128/jcm.27.10.2148-2151.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Adherence of Streptococcus agalactiae to synchronously growing human cell monolayers without lipoteichoic acid involvement.

Authors:  S Miyazaki; O Leon; C Panos
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

2.  Immuno-electronmicroscopic demonstration of capsules on group-B streptococci of new serotypes and type candidates.

Authors:  M Rýc; J Jelínková; J Motlová; M Wagner
Journal:  J Med Microbiol       Date:  1988-02       Impact factor: 2.472

3.  Structural determination of the capsular polysaccharide antigen of type II group B Streptococcus.

Authors:  H J Jennings; K G Rosell; E Katzenellenbogen; D L Kasper
Journal:  J Biol Chem       Date:  1983-02-10       Impact factor: 5.157

4.  Biosynthetic capacity for type-specific antigen synthesis determines the virulence of serotype III strains of group B streptococci.

Authors:  M K Yeung; S J Mattingly
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

5.  The effect of hybridoma antibody administration upon neutrophil kinetics during experimental type III group B streptococcal sepsis.

Authors:  R D Christensen; G Rothstein; H R Hill; S H Pincus
Journal:  Pediatr Res       Date:  1983-10       Impact factor: 3.756

6.  Strain differences in virulence of group B streptococci.

Authors:  J I Santos; A O Shigeoka; H R Hill
Journal:  Pediatr Res       Date:  1982-05       Impact factor: 3.756

7.  Role of cellular lipoteichoic acids in mediating adherence of serotype III strains of group B streptococci to human embryonic, fetal, and adult epithelial cells.

Authors:  T J Nealon; S J Mattingly
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

8.  In vitro method to differentiate isolates of type III Streptococcus agalactiae from symptomatic and asymptomatic patients.

Authors:  J J Maurer; S J Mattingly
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

9.  Kinetic and chemical analyses of the biologic significance of lipoteichoic acids in mediating adherence of serotype III group B streptococci.

Authors:  T J Nealon; S J Mattingly
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

10.  Isolation and characterization of type III group B streptococcal mutants defective in biosynthesis of the type-specific antigen.

Authors:  M K Yeung; S J Mattingly
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

View more
  3 in total

1.  Loss of catabolic function in Streptococcus agalactiae strains and its association with neonatal meningitis.

Authors:  Anne-Sophie Domelier; Nathalie van der Mee-Marquet; Adeline Grandet; Laurent Mereghetti; Agnès Rosenau; Roland Quentin
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

2.  Prophagic DNA fragments in Streptococcus agalactiae strains and association with neonatal meningitis.

Authors:  Nathalie van der Mee-Marquet; Anne-Sophie Domelier; Laurent Mereghetti; Philippe Lanotte; Agnès Rosenau; Willem van Leeuwen; Roland Quentin
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

3.  Screening of type Ia and Ib Streptococcus agalactiae strains with high sialic acid levels by determination of susceptibility to tetracyclines.

Authors:  Y Nagano; N Nagano; S Takahashi; A Suzuki; Y Okuwaki
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.